These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 12118327

  • 1. Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors.
    Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tokuda M.
    Int J Oncol; 2002 Aug; 21(2):315-20. PubMed ID: 12118327
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression of survivin is associated with malignant potential in epithelial ovarian carcinoma.
    Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I.
    Int J Mol Med; 2002 Aug; 10(2):211-6. PubMed ID: 12119561
    [Abstract] [Full Text] [Related]

  • 5. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung.
    Ikehara M, Oshita F, Kameda Y, Ito H, Ohgane N, Suzuki R, Saito H, Yamada K, Noda K, Mitsuda A.
    Oncol Rep; 2002 Aug; 9(4):835-8. PubMed ID: 12066218
    [Abstract] [Full Text] [Related]

  • 6. B7-H4 overexpression in ovarian tumors.
    Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J, Shroyer KR.
    Gynecol Oncol; 2006 Jan; 100(1):44-52. PubMed ID: 16256178
    [Abstract] [Full Text] [Related]

  • 7. Expression of p57kip2 and its clinical relevance in epithelial ovarian tumors.
    Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tokuda M.
    Anticancer Res; 2002 Jan; 22(6A):3191-6. PubMed ID: 12530064
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
    Høgdall EV, Christensen L, Høgdall CK, Blaakaer J, Gayther S, Jacobs IJ, Christensen IJ, Kjaer SK.
    Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
    [Abstract] [Full Text] [Related]

  • 9. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL, Shen DH, Xue WC, Li Y, Yu YZ.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human kallikrein 8 (hK8/TADG-14) expression is associated with an early clinical stage and favorable prognosis in ovarian cancer.
    Shigemasa K, Tian X, Gu L, Tanimoto H, Underwood LJ, O'Brien TJ, Ohama K.
    Oncol Rep; 2004 Jun; 11(6):1153-9. PubMed ID: 15138549
    [Abstract] [Full Text] [Related]

  • 14. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis.
    Cohen C, Lohmann CM, Cotsonis G, Lawson D, Santoianni R.
    Mod Pathol; 2003 Jun; 16(6):574-83. PubMed ID: 12808063
    [Abstract] [Full Text] [Related]

  • 15. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.
    Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y, Tokuda M.
    Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512
    [Abstract] [Full Text] [Related]

  • 16. Survivin expression in intracranial ependymomas and its correlation with tumor cell proliferation and patient outcome.
    Preusser M, Wolfsberger S, Czech T, Slavc I, Budka H, Hainfellner JA.
    Am J Clin Pathol; 2005 Oct; 124(4):543-9. PubMed ID: 16146813
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

  • 18. Proliferative activity and p53 over-expression of ovarian epithelial tumors.
    Kuwata T, Kitagawa M, Takemura T, Hirokawa K.
    Gen Diagn Pathol; 1995 Oct 15; 141(2):131-9. PubMed ID: 8548593
    [Abstract] [Full Text] [Related]

  • 19. [Expression and clinical significance of uPA and PAI-1 in epithelial ovarian cancer].
    Cai Z, Li YF, Liu FY, Feng YL, Hou JH, Zhao MQ.
    Ai Zheng; 2007 Mar 15; 26(3):312-7. PubMed ID: 17355798
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.